ARDT Ardent Health, Inc.
P/E
22.72
Forward P/E
9.57
Price/Sales
0.27
Beta
0.717
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Ardent Health's third quarter 2026 revenue of $1.6B beat estimates with raised EBITDA guidance
Ardent Health reported third quarter 2026 results that exceeded analyst expectations on both the top and bottom lines. Performance was driven by sequential...
Ardent Health Partners, Inc. Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026
Ardent Health Partners is expected to report Q3 2026 revenue of $1.60 billion and EPS of $0.24, with its current $11.85 share price trading below the $13.00...
Ardent Health Halts Severance for Former CEO After Reclassifying Termination 'For Cause'
Ardent Health, Inc. has recharacterized the June 2, 2026 departure of former President and CEO Martin J. Bonick as a termination "for Cause." This decision,...